General MedicationsORALStandard
RANITIDINE HYDROCHLORIDE
RANITIDINE HYDROCHLORIDE
Standard Dose
EQ 300MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview RANITIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 211289 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RANITIDINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 300MG BASE Sponsor VKT PHARMA Submission history Latest submission status date: 2019-08-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview RANITIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 211289 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RANITIDINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 300MG BASE Sponsor VKT PHARMA Submission history Latest submission status date: 2019-08-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.